Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BNXTFNASDAQ:BWAYNASDAQ:JYNTNASDAQ:LNSR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBNXTFBioNxt Solutions$0.34+4.6%$0.36$0.11▼$0.43$39.36M0.5610,246 shs31,000 shsBWAYBrainsWay$8.95-2.8%$9.30$4.80▼$11.79$166.99M1.1772,643 shs33,713 shsJYNTJoint$10.15-3.2%$11.11$9.58▼$17.82$155.53M1.4555,599 shs43,630 shsLNSRLENSAR$14.03+0.9%$13.62$2.95▼$17.31$165.40M0.5671,807 shs223,556 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBNXTFBioNxt Solutions0.00%-4.14%-8.11%+21.56%+13.33%BWAYBrainsWay0.00%+11.77%-0.97%-12.03%+93.49%JYNTJoint0.00%+4.80%-17.08%-5.75%-14.23%LNSRLENSAR0.00%0.00%-1.56%+30.00%+329.32%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBNXTFBioNxt SolutionsN/AN/AN/AN/AN/AN/AN/AN/ABWAYBrainsWay3.2275 of 5 stars3.53.00.00.03.50.81.9JYNTJoint3.2214 of 5 stars3.52.00.00.02.03.31.9LNSRLENSAR0.814 of 5 stars1.03.00.00.02.82.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBNXTFBioNxt Solutions 0.00N/AN/AN/ABWAYBrainsWay 3.00Buy$13.1747.11% UpsideJYNTJoint 3.00Buy$17.5072.41% UpsideLNSRLENSAR 2.00Hold$15.006.91% UpsideCurrent Analyst Ratings BreakdownLatest BNXTF, BWAY, LNSR, and JYNT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/24/2025LNSRLENSARBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/24/2025LNSRLENSARLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$16.00 ➝ $15.003/12/2025BWAYBrainsWayHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.002/28/2025LNSRLENSARLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$12.00 ➝ $16.00(Data available from 4/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBNXTFBioNxt Solutions$280K140.57N/AN/A($0.04) per share-8.50BWAYBrainsWay$41.02M4.12N/AN/A$2.50 per share3.58JYNTJoint$51.90M3.00$0.65 per share15.65$1.68 per share6.04LNSRLENSAR$53.49M3.09N/AN/A$2.97 per share4.72Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBNXTFBioNxt Solutions-$5.72M-$0.04N/A∞N/A-15,638.71%N/A-683.78%N/ABWAYBrainsWay-$4.20M$0.1789.5155.94N/A3.88%3.52%2.26%5/6/2025 (Estimated)JYNTJoint-$9.75M-$0.57N/A19.15N/A-13.95%8.24%2.33%5/8/2025 (Estimated)LNSRLENSAR-$14.38M-$2.72N/A∞N/A-34.03%-49.02%-21.12%5/8/2025 (Estimated)Latest BNXTF, BWAY, LNSR, and JYNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025BWAYBrainsWay$0.02N/AN/AN/A$11.45 millionN/A5/8/2025Q1 2025JYNTJoint-$0.02N/AN/AN/A$13.02 millionN/A5/8/2025Q1 2025LNSRLENSAR-$0.1550N/AN/AN/A$13.40 millionN/A2/27/2025Q4 2024LNSRLENSAR-$0.21-$1.61-$1.40-$1.61$14.95 million$16.73 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBNXTFBioNxt SolutionsN/AN/AN/AN/AN/ABWAYBrainsWayN/AN/AN/AN/AN/AJYNTJointN/AN/AN/AN/AN/ALNSRLENSARN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBNXTFBioNxt SolutionsN/A0.040.04BWAYBrainsWayN/A4.524.23JYNTJointN/A1.441.44LNSRLENSARN/A3.372.10Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBNXTFBioNxt SolutionsN/ABWAYBrainsWay30.11%JYNTJoint76.88%LNSRLENSAR40.15%Insider OwnershipCompanyInsider OwnershipBNXTFBioNxt SolutionsN/ABWAYBrainsWay19.00%JYNTJoint27.90%LNSRLENSAR38.52%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBNXTFBioNxt Solutions20115.76 millionN/ANot OptionableBWAYBrainsWay12018.87 million15.24 millionNot OptionableJYNTJoint32015.32 million10.46 millionOptionableLNSRLENSAR11011.79 million7.14 millionOptionableBNXTF, BWAY, LNSR, and JYNT HeadlinesRecent News About These CompaniesRenaissance Technologies LLC Grows Stock Position in LENSAR, Inc. (NASDAQ:LNSR)April 26 at 3:39 AM | marketbeat.comLENSAR (NASDAQ:LNSR) Stock Price Up 0.1% - Still a Buy?April 26 at 2:34 AM | marketbeat.comLENSAR, Inc. (NASDAQ:LNSR) Short Interest UpdateApril 21, 2025 | marketbeat.comIs LENSAR (LNSR) a Deeply Undervalued Stock?April 10, 2025 | msn.comLENSAR (NASDAQ:LNSR) Cut to "Hold" at BTIG ResearchMarch 28, 2025 | marketbeat.comLENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSRMarch 26, 2025 | businesswire.comLensar downgraded to Hold from Buy at Lake StreetMarch 26, 2025 | markets.businessinsider.comALC Stock Rises Following the Merger Agreement With LENSARMarch 25, 2025 | zacks.comLake Street Downgrades LENSAR (LNSR)March 25, 2025 | msn.comShareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public ShareholdersMarch 24, 2025 | tmcnet.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating LENSAR, Inc. BuyoutMarch 24, 2025 | markets.businessinsider.comLake Street Reaffirms Their Buy Rating on LENSAR (LNSR)March 24, 2025 | markets.businessinsider.com$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of LENSAR, Inc. - LNSRMarch 24, 2025 | prnewswire.comLNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. Is Fair to ShareholdersMarch 24, 2025 | businesswire.comLENSAR - Top Healthcare Equipment StockMarch 6, 2025 | msn.comLENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 3, 2025 | globenewswire.comLENSAR, Inc. (NASDAQ:LNSR) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | msn.comLensar price target raised to $16 from $12 at Lake StreetMarch 1, 2025 | markets.businessinsider.comLENSAR Inc (LNSR) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ...February 28, 2025 | finance.yahoo.comLensar sees 2025 revenue growth above 27% from $53.5M in 2024February 28, 2025 | markets.businessinsider.comLENSAR, Inc. Reports Strong 2024 Financial PerformanceFebruary 28, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBNXTF, BWAY, LNSR, and JYNT Company DescriptionsBioNxt Solutions OTCMKTS:BNXTF$0.34 +0.02 (+4.62%) As of 04/25/2025 01:19 PM EasternBioNxt Solutions Inc. engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains. In addition, the company offers psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. Further, it provides analytical testing and consulting services. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.BrainsWay NASDAQ:BWAY$8.95 -0.26 (-2.82%) Closing price 04:00 PM EasternExtended Trading$9.16 +0.21 (+2.34%) As of 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.Joint NASDAQ:JYNT$10.15 -0.34 (-3.24%) Closing price 04:00 PM EasternExtended Trading$10.14 -0.01 (-0.05%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.LENSAR NASDAQ:LNSR$14.03 +0.12 (+0.86%) Closing price 04:00 PM EasternExtended Trading$14.02 0.00 (-0.04%) As of 06:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Rebounds After Strong Earnings and Buyback Announcement Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret? The Bear Market Has Only Just Started - Here's Why MarketBeat Week in Review – 04/21 - 04/25 3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S. PepsiCo’s Stock Price is Disconnected From Reality: Time to Buy Bears Can Reap Big Benefits With These 3 Short ETF Bets Why Institutions Are Buying Super Micro Computer Stock Again Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
